Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and …
Context Accurate staging of high-risk localised, advanced, and metastatic prostate cancer is
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …
Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic …
M Perera, N Papa, D Christidis, D Wetherell… - European urology, 2016 - Elsevier
Context Positron emission tomography (PET) of 68 Ga-labelled prostate-specific membrane
antigen (68 Ga-PSMA) is an emerging imaging modality introduced to assess the burden of …
antigen (68 Ga-PSMA) is an emerging imaging modality introduced to assess the burden of …
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
Purpose: Current FDA-approved imaging modalities are inadequate for localizing prostate
cancer biochemical recurrence (BCR). 18F-DCFPyL is a highly selective, small-molecule …
cancer biochemical recurrence (BCR). 18F-DCFPyL is a highly selective, small-molecule …
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients …
Purpose: Prostate specific membrane antigen-targeted positron emission tomography/
computerized tomography has the potential to improve the detection and localization of …
computerized tomography has the potential to improve the detection and localization of …
[HTML][HTML] Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre …
Summary Background Lutetium-177 (177 Lu) prostate-specific membrane antigen (177 Lu-
PSMA) is a novel targeted treatment for patients with metastatic castration-resistant prostate …
PSMA) is a novel targeted treatment for patients with metastatic castration-resistant prostate …
Current use of PSMA–PET in prostate cancer management
T Maurer, M Eiber, M Schwaiger… - Nature Reviews …, 2016 - nature.com
Currently, the findings of imaging procedures used for detection or staging of prostate
cancer depend on morphology of lymph nodes or bone metabolism and do not always meet …
cancer depend on morphology of lymph nodes or bone metabolism and do not always meet …
Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …
Matched-pair comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical …
I Rauscher, M Krönke, M König, A Gafita… - Journal of nuclear …, 2020 - Soc Nuclear Med
18F-labeled prostate-specific membrane antigen (PSMA)–ligand PET has several principal
advantages over 68Ga-PSMA-11. The purpose of this retrospective study was to evaluate …
advantages over 68Ga-PSMA-11. The purpose of this retrospective study was to evaluate …
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
S Sheikhbahaei, A Afshar-Oromieh, M Eiber… - European journal of …, 2017 - Springer
Background The rapidly expanding clinical adaptation of prostate-specific membrane
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …
[HTML][HTML] Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a …
H Grünig, A Maurer, Y Thali, Z Kovacs, K Strobel… - European Journal of …, 2021 - Springer
Purpose Improved logistics and availability led to a rapid increase in the use of [18 F]-PSMA-
1007 for prostate cancer PET imaging. Initial data suggests increased uptake in benign …
1007 for prostate cancer PET imaging. Initial data suggests increased uptake in benign …